1 |
Berghmans T, Mascaux C, Martin B, et al (2006). Prognostic role of thyroid transcription factor-1 in stage III non-small cell lung cancer. Lung Cancer, 52, 219-24.
DOI
|
2 |
Berghmans T, Paesmans M, Sculier J P (2011). Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables. Ther Adv Med Oncol, 3, 127-38.
DOI
|
3 |
Chabot B, Stephenson D A, Chapman V M, et al (1988). The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature, 335, 88-9.
DOI
|
4 |
Edling C E, Hallberg B (2007). c-Kit-a hematopoietic cell essential receptor tyrosine kinase. Int J Biochem Cell Biol, 39, 1995-8.
DOI
|
5 |
Ettinger D S, Akerley W, Borghaei H, et al (2012). Non-small cell lung cancer. J Natl Compr Canc Netw, 10, 1236-71.
DOI
|
6 |
Gazdar A F , Schiller J H (2011). Predictive and prognostic factors for non-small cell lung cancer-potholes in the road to the promised land. J Natl Cancer Inst, 103, 1810-1.
DOI
|
7 |
Grossi F , Spizzo R, Bordo D, et al (2010). Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an alpe adria thoracic oncology multidisciplinary group study (ATOM 014). J Thorac Oncol, 5, 1354-60.
DOI
|
8 |
Herpel E, Jensen K, Muley T, et al (2011). The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. Anticancer Res, 31, 4491-500.
|
9 |
Kalemkerian GP, Akerley W, Bogner P, et al (2013). Small cell lung cancer. J Natl Compr Canc Netw, 11, 78-98.
DOI
|
10 |
Liberati A, Altman D G, Tetzlaff J, et al (2009). The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions:explanation and elaboration. Ann Intern Med, 151, 65-94.
|
11 |
Lu H Y, Zhang G, Cheng Q Y, et al (2012). Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer. Oncol Lett, 4, 89-93.
DOI
|
12 |
Mascaux C, Iannino N, Martin B, et al (2005). The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer, 92, 131-9.
DOI
|
13 |
Matsumura Y , Umemura S, Ishii G, et al (2015). Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma. J Cancer Res Clin Oncol, 1-12.
|
14 |
McCarty Jr K, Miller L, Cox E, et al (1985). Estrogen receptor analyses. correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med, 109, 716-21.
|
15 |
Medinger M, Kleinschmidt M, Mross K, et al (2010). c-kit (CD117) expression in human tumors and its prognostic value: an immunohistochemical analysis. Pathol Oncol Res, 16, 295-301.
DOI
|
16 |
Nakamura H, Kawasaki N, Taguchi M, et al (2006). Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis. Thorax, 61, 140-5.
DOI
|
17 |
Siegel R, Ma J, Zou Z, et al (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29.
DOI
|
18 |
Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
DOI
|
19 |
Xiao H, Wang J, Liu Y, et al (2014). Relative influence of c-Kit expression and epidermal growth factor receptor gene amplification on survival in patients with non-small cell lung cancer. Oncol Lett, 8, 582-8.
DOI
|
20 |
Ashman LK (1999). The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol, 31, 1037-51.
DOI
|
21 |
Zhao F, Chen Y, Wu Q, et al (2014). Prognostic value of CD117 in cancer: a meta-analysis. Int J Clin Exp Pathol, 7, 1012-21.
|